RecruitingPhase 4NCT06853665

The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine

Studying Interatrial communication

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Gagan Joshi
Principal Investigator
Gagan Joshi, MD
Massachusetts General Hospital
Intervention
Adderall XR (mixed salts amphetamine)(drug)
Enrollment
196 target
Eligibility
8-18 years · All sexes
Timeline
2026 – 2030

Study locations (1)

Collaborators

Massachusetts Institute of Technology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06853665 on ClinicalTrials.gov

Other trials for Interatrial communication

Additional recruiting or active studies for the same condition.

See all trials for Interatrial communication →

← Back to all trials